clear search
Search
Search Suggestions
Recent searches Clear History
Talk with Us

Whole Allergen

m15 Trichoderma viride

m15 Trichoderma viride Scientific Information

Type:

Whole Allergen

Display Name:

Trichoderma viride

Route of Exposure:

Inhalation

Family:

Hypocreaceae

Species:

viride

Latin Name:

Trichoderma viride

Other Names:

Hypocrea rufa; green mold of narcissus

Summary

Trichoderma viride (Hypocrea rufa) is a ubiquitous mold of the Order Hypocreales, mostly found in plant materials and soil worldwide. It shows a variety of phenotypes and interactions with plants, other fungi and life forms. The particles causing allergic reactions are spores found in the environment.

Hypersensitivity pneumonitis (HP) and asthma are the main clinical presentations of T. viride allergy; molds of the Trichoderma genus are also able to cause opportunistic disease. Cross reactivity with other molds, especially if taxonomically close, may occur.

Allergen

Nature

The Genus Trichoderma is a group of common filamentous fungi showing a wide range of phenotypes and interactions with other life forms (1). Trichoderma viride is the anamorph (asexual form) of the fungus Hypocrea rufa (teleomorph, the asexual form) (1, 2). T. viride can grow on a wide variety of substrates, including wood (from many plant species), soil, leaf litter, peat, bark, water-damaged buildings (2) and other moldy, damp buildings (3). It was isolated in 22% of surface-derived water samples, and frequently found throughout the water systems (4).

Most Trichoderma tipically produce copious large amounts of green conidia, organized in pustules (1-5 mm) or “lawns” when cultured in vitro. Pustules appear cottony, with individual fertile branches and conidiophores protruding beyond the surface. In cultures of T. viride, conidia often formed at the surface of a pustule and reached a deep-dark green color after a week. Various types of conidia are produced, though warted (i.e. presenting warts on the surface)(5), is the most common; size also varies, with a wide range of 3–5.5 by 2.8–5 μm. Optimal growth temperature was 25°C (2). T. viride colonies may have a coconut-like odor (5).

There is considerable overlap between peak fungal activity season and other allergens such as grass and weed pollens, often masking the pathology caused by fungal spores in multi-sensitized people (6). Trichoderma spp contributed on average to 0.23% of the total mold spores caught during a study spanning a 2-year period (7).

Trichoderma viride may prove to be a bio-control agent against plant pathogens (8), though it is not believed to produce antibiotics (5).

Taxonomy 

Taxonomic tree of Trichoderma genus (9)

Domain

Eukaryota

Kingdom

Fungi

Phylum

Ascomycota

Subphylum

Pezizomycotina

Class

Sordariomycetes

Order

Hypocreales

Family

Hypocreaceae

Genus

Trichoderma

Taxonomic tree of Trichoderma genus (9)

Tissue 

Spores release detectable amounts of allergens following germination (6, 7, 10). T. viride spores were more likely to be found in dust samples than air (11).

Epidemiology

Worldwide distribution 

Allergic disease caused by Trichoderma viride has been described in several countries around the world, including India (7), USA (11, 12), Spain (13), and Sweden (14).

Risk factors 

Occupational health risks may be present for workers handling fungal enzymes in the animal feed industry, specifically phytase produced by Trichoderma spp. (15) and cellulase (16). Water-damaged, moldy homes may present a higher risk of developing asthma due to T. viride sensitization (11).

Environmental Characteristics

Worldwide distribution 

T. viride has been identified worldwide (2, 17).

Route of Exposure

Main

Inhalation of spores, which appeared at higher concentration in dust than air samples (11), are able to reach the lung alveoli (3).

Detection

Main methods 

Personal volumetric petri plate sampler (7)

Measures 

The concentrations of Trichoderma spp spores ranged between 1–15 CFU/m3 (7).

Clinical Relevance

In a study of patients with pre-existing allergies, 35% showed positive reactions to a Trichoderma viridae cellulase, showing evidence of sensitization in the workplace (16).

T. viride spores are able to reach the alveoli, and in an in vitro study were found to trigger histamine release from bronchoalveolar lavage (BAL) cells (3).

In a 54-year old patient who presented with dyspnea, cough, chest pain and fever, T. viride caused hypersensitivity pneumonitis (HP). T. viride was cultured from the patient’s humidifier, and specific precipitating IgG were present in the patient’s serum (13).

Asthma

Trichoderma viride was amongst the molds that showed significantly higher concentrations in the homes of asthmatic children, compared with control homes (11). 

Other diseases

T. viride is able to cause opportunistic lung infections in immunocompromised patients (18).

Other topics

A closely related fungal species, T. longibrachiatum, was the causative agent of allergic fungal sinusitis (AFS) in a 52-year old atopic and asthmatic patient who complained of headaches, nasal congestion and sinus pressure (19). Research into IgG reactivity to fungal agents showed that another Trichoderma species related to T. viride, T. citrinoviride could be a causative agent of adult-onset asthma (20).

Diagnostics Sensitization

The presence of allergen-specific antibodies is usually determined by skin prick tests (SPTs) and serology for IgE (6, 7). Radioallergosorbent Assays (RAST) may also be used to determine the ability of IgE to bind specific allergens (21). In a study of 102 patients reporting symptoms of allergic rhinitis or asthma, between 4–8% had a positive SPT result to T. viride antigen preparations (the difference was attributed by differing manufacturing process of the extracts) (12). In another study of 150, SPT reactions to Trichoderma viride allergens in patients with respiratory allergies varied in positivity, with 30% of patients showing mild to moderately positive reactions, 8.7% showing moderately positive reactions and 3.3% showing highly positive skin reactions (7). In the same study, the serum of SPT+ (positive) patients was tested by ELISA for the presence of IgE specific for the fungal antigens that caused the positive skin reactions. This showed 16.7% concordance for T. viride antigens when comparing the skin-prick tests and the ELISA in vitro immunoassay (7). A study using RAST to determine the IgE specificity of serum from patients with respiratory allergies showed that 7 of 20 patients had IgE for a T. viride cellulase (21).

Prevention and Therapy

Allergen immunotherapy

Immunotherapy is currently not recommended for patients allergic to molds, due to complexities of the allergens and patient co-allergies (6).

Prevention strategies 

Avoidance is difficult to achieve (6), due to the wide range of environments in which T. viride can be found (2, 17).

Molecular Aspects

Cross-reactivity

Cross-reactivity has been demonstrated to other molds. In a study carried out on 668 serum samples from patients who had previously recorded at least one IgE positivity to fungal antigens, associations were observed between the patterns of IgE sensitization and fungal phylogenetic relationships. Using a panel of 17 fungal extracts including T. viride, some samples were only positive to one fungal species, whereas many were multi-sensitized. The results suggest that the associations are likely due to antigen cross-reactivity between fungal species, not uncommon in more closely related species (14).

Compiled By

Author: RubyDuke Communications

Reviewer: Dr. Christian  Fischer

 

Last reviewed:January 2022

References
  1. Atanasova L. Chapter 2 - Ecophysiology of Trichoderma in Genomic Perspective. In: Gupta VK, Schmoll M, Herrera-Estrella A, Upadhyay RS, Druzhinina I, Tuohy MG, editors. Biotechnology and Biology of Trichoderma. Amsterdam: Elsevier; 2014. p. 25-40.
  2. Jaklitsch WM, Samuels GJ, Dodd SL, Lu BS, Druzhinina IS. Hypocrea rufa/Trichoderma viride: a reassessment, and description of five closely related species with and without warted conidia. Stud Mycol. 2006;56:135-77.
  3. Larsen FO, Clementsen P, Hansen M, Maltbaek N, Gravesen S, Skov PS, et al. The indoor microfungus Trichoderma viride potentiates histamine release from human bronchoalveolar cells. Apmis. 1996;104(9):673-9.
  4. Hageskal G, Vrålstad T, Knutsen AK, Skaar I. Exploring the species diversity of Trichoderma in Norwegian drinking water systems by DNA barcoding. Mol Ecol Resour. 2008;8(6):1178-88.
  5. Lieckfeldt E, Samuels GJ, Nirenberg HI, Petrini O. A morphological and molecular perspective of Trichoderma viride: is it one or two species? Appl Environ Microbiol. 1999;65(6):2418-28.
  6. Twaroch TE, Curin M, Valenta R, Swoboda I. Mold allergens in respiratory allergy: from structure to therapy. Allergy Asthma Immunol Res. 2015;7(3):205-20.
  7. Kochar S, Ahlawat M, Dahiya P, Chaudhary D. Assessment of allergenicity to fungal allergens of Rohtak city, Haryana, India. Allergy Rhinol (Providence). 2014;5(2):56-65.
  8. Yashavantha Rao HC, Chandra Mohana N, Satish S. 13 - Biocommercial aspects of microbial endophytes for sustainable agriculture. In: Kumar A, E.K R, editors. Microbial Endophytes: Woodhead Publishing; 2020. p. 323-47.
  9. Uniprot.org. Taxonomy - Hypocrea rufa (Trichoderma viride) (SPECIES) 2021 [cited 2021 30.11.21]. Available from: https://www.uniprot.org/taxonomy/5547.
  10. Green BJ, Mitakakis TZ, Tovey ER. Allergen detection from 11 fungal species before and after germination. J Allergy Clin Immunol. 2003;111(2):285-9.
  11. Vesper SJ, McKinstry C, Yang C, Haugland RA, Kercsmar CM, Yike I, et al. Specific molds associated with asthma in water-damaged homes. J Occup Environ Med. 2006;48(8):852-8.
  12. Beezhold DH, Green BJ, Blachere FM, Schmechel D, Weissman DN, Velickoff D, et al. Prevalence of allergic sensitization to indoor fungi in West Virginia. Allergy Asthma Proc. 2008;29(1):29-34.
  13. Enríquez-Matas A, Quirce S, Melchor R, rodriguez nieto mj, Carnés J, Madero M, et al. Hypersensitivity Pneumonitis Caused by Trichoderma Viride. Journal of Allergy and Clinical Immunology. 2007;119:S22.
  14. Soeria-Atmadja D, Onell A, Borgå A. IgE sensitization to fungi mirrors fungal phylogenetic systematics. J Allergy Clin Immunol. 2010;125(6):1379-86.e1.
  15. Caballero ML, Gómez M, González-Muñoz M, Reinoso L, Rodríguez-Pérez R, Alday E, et al. Occupational Sensitization to Fungal Enzymes Used in Animal Feed Industry. International Archives of Allergy and Immunology. 2007;144(3):231-9.
  16. Green BJ, Beezhold DH. Industrial fungal enzymes: an occupational allergen perspective. J Allergy (Cairo). 2011;2011:682574.
  17. CABI. Hypocrea rufa (green mould of narcissus) Wallingford, UK2021 [cited 2021 30.11.21]. Available from: https://www.cabi.org/isc/datasheet/54471.
  18. De Miguel D, Gómez P, González R, García-Suárez J, Cuadros JA, Bañas MH, et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect Dis. 2005;53(1):33-7.
  19. Tang P, Mohan S, Sigler L, Witterick I, Summerbell R, Campbell I, et al. Allergic fungal sinusitis associated with Trichoderma longibrachiatum. J Clin Microbiol. 2003;41(11):5333-6.
  20. Jaakkola MS, Laitinen S, Piipari R, Uitti J, Nordman H, Haapala AM, et al. Immunoglobulin G antibodies against indoor dampness-related microbes and adult-onset asthma: a population-based incident case-control study. Clin Exp Immunol. 2002;129(1):107-12.
  21. Horner WE, Armstrong M, El-Dahr J, McCants M, Reese G, Kobernick AK, et al. Prevalence of IgE reactivities in mold-allergic subjects to commercially available fungal enzymes. Allergy Asthma Proc. 2008;29(6):629-35.